Track side effects
Takeda Pharmaceuticals America, Inc
Studies show that at max dosage, patients using tirzepatide saw 17.8% weight loss, while patients using semaglutide saw a 12.4% weight loss (2, 3, 4)
Baseline measurements obtained from the participants determined that 64% of the participants were male, while the mean age was 58 years old, average diabetes duration was approximaely 9 years, the mean HbA1c was recorded at 8.4%, as well as an average body weight of 105.7 kg
What the Research Shows Clinical trials have consistently shown liver benefits from GLP-1 medications in patients with fatty liver disease
Sexual Medicine, 4 (3), e166